Najla Guthrie is revolutionizing the way we treat and talk about wellness. As the CEO of KGK Science and Wellbeing Digital Science, Najla is a global leader in the nutraceutical and emerging psychedelic industry with a focus on fundamentally changing the way we treat and prevent mental illness.
Her original research at Centre for Human Nutrition at the University of Western Ontario led to the development of a cholesterol lowering product that is still on the market today and was the catalyst for the founding of KGK Science.
Najla has since published over 50 papers in peer-reviewed journals, holds over 20 US and International patents, and serves on the NPC Board of Directors, and is a shareholder in numerous cannabis and nutrition businesses.
She founded and grew KGK Science, a full-service premium contract research organization. Creating a business that focuses on high-quality clinical research and regulatory expertise to bring safe and effective products to global markets.
When KGK partnered with Wellbeing Digital Science, an evidence-based healthcare company focused on innovative clinical solutions, her expertise and passion made her a great fit to take on the role of CEO.
Today, Najla continues to present and speak at a global level, lobby for the advancement of policy changes in the supplement and cannabis industries and lead the team at Wellbeing Digital Science and KGK Science.
Najla is driven by impact and is proud to be a first generation immigrant and female leader in STEM leading the way for more voices to be shared in the industry.
Her latest initiative, the Women in Psychedelic Network, is an opportunity for women in the psychedelic space to collaborate and leverage their collective voice in a male-dominated industry.